This week's FierceBiotech is brought to you by Patheon.

                                                           
   
 
   
 
How accurate is your biologic drug substance forecast?
 
 
Read the report
   

WP_InaccurateForecasting_170x220.PNGLarge molecule drug substance manufacturing and demand forecasting is riddled with complexity. The long cycle time and short shelf life of a biologic drug substance makes it difficult to adapt the supply chain with agility, even at the earliest stages of development. As a result, inaccurate demand forecasts can have significant implications for companies developing biologics. And with less industry-wide available capacity for biologic production, it is increasingly difficult to locate capacity to respond to demand changes and ensure products achieve commercial goals.

Download the report "Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing" to learn more about causes, consequences and potential solutions to forecasting challenges specifically related to biologic drug substance manufacturing.

 
Read the report
 
 
 
 
Patheon Logo.PNG

Patheon, 4815 Emperor Blvd., Durham, NC 27703-8470, USA
+1 866-728-4366 |  +1 919-226-3200 |  doingbusiness@patheon.com |  Privacy Policy

Want to reach 150,000+ FierceBiotech subscribers with your own message?
Contact aalcover@fiercemarkets.com or call 202-824-5074.



About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech.
Click here to unsubscribe.

FierceMarkets, a division of Questex, LLC
1900 L St. NW Suite 400 
Washington, DC 20036

.